News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current IDXG market cap is 16.94M. The company's latest EPS is USD 0.1856 and P/E is 9.05.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.03M | 9.08M | 10.28M | 10.27M | 12.04M |
| Operating Income | 833k | -17k | 1.31M | 874k | 2.26M |
| Net Income | 175k | -614k | 890k | 468k | 2.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.12M | 32.89M | 41.65M | 32.06M | 40.21M |
| Operating Income | -26.42M | -26.07M | -14M | -3.62M | 2.8M |
| Net Income | -27.16M | -29.48M | -14.94M | -21.96M | 802k |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.94M | 14.25M | 13.02M | 12.14M | 12.97M |
| Total Liabilities | 31.61M | 30.39M | 28.16M | 26.75M | 25.46M |
| Total Equity | -62.21M | -62.68M | -61.67M | -61.14M | -59.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 69.05M | 45.68M | 38.43M | 15.98M | 13.02M |
| Total Liabilities | 29.85M | 28.23M | 34.31M | 32.52M | 28.16M |
| Total Equity | 13.03M | -29.08M | -42.42M | -63.07M | -61.67M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.54M | 2.65M | 3.79M | -58k | 1.35M |
| Investing | -293k | 55k | -87k | -28k | -225k |
| Financing | -1M | -2.5M | -5.03M | -600k | -2.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.96M | -13.98M | -8.72M | -7.69M | 3.79M |
| Investing | -13.95M | -1.58M | -315k | 6.21M | -87k |
| Financing | 29.16M | 16.61M | 8.98M | 3M | -5.03M |
| Market Cap | 16.94M |
| Price to Earnings Ratio | 9.05 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 2.08 |
| Price to Book Ratio | -0.48 |
| Dividend Yield | - |
| Shares Outstanding | 4.32M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.11 (2.74%) |
| Company Name | Interpace Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.interpace.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
